Dry eye disease is a multifactorial condition with significant implications for ocular surface health and patient quality of life. Autologous serum eye drops (ASED) have emerged as an effective biologic treatment, offering essential growth factors, anti-inflammatory mediators, and tear film stabilizers for dry eye patients from moderate to severe. This lecture explores the pathophysiology of dry eye subtypes that benefit from ASEDs, the biochemical composition of serum-based therapy, and the clinical protocols for prescribing serum tears. Attendees will gain a deeper understanding of ASED's role in personalized ocular surface management and learn how to integrate this treatment option into clinical practice.

Speaker: Dr. Cecelia Koetting

Date: Tuesday, September 9, 2025

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour of CE credit.